FGF23 and neoplasm: In 2009, Bahrami et al. [12] reported the diagnostic utility of detecting FGF23 transcripts in PMTs by the reverse transcription-polymerase chain reaction (RT-PCR) using formalin-fixed, paraffin-embedded (FFPE) tumor tissues.